Eman Soliman

1.1k total citations
45 papers, 764 citations indexed

About

Eman Soliman is a scholar working on Molecular Biology, Pharmacology and Agronomy and Crop Science. According to data from OpenAlex, Eman Soliman has authored 45 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Pharmacology and 7 papers in Agronomy and Crop Science. Recurrent topics in Eman Soliman's work include Animal Disease Management and Epidemiology (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Viral Infections and Immunology Research (6 papers). Eman Soliman is often cited by papers focused on Animal Disease Management and Epidemiology (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Viral Infections and Immunology Research (6 papers). Eman Soliman collaborates with scholars based in Egypt, United States and Grenada. Eman Soliman's co-authors include Rukiyah Van Dross, Shimaa M. Elshazly, Daniel A. Ladin, LaToya M. Griffin, Amr A. A. Mahmoud, Mona F. Mahmoud, Allison S. Danell, Nabila N. El‐Maraghy, Ken Soderstrom and Michelle H. Theus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Eman Soliman

44 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eman Soliman Egypt 17 259 244 101 81 80 45 764
Maíra Cola Brazil 17 164 0.6× 305 1.3× 87 0.9× 130 1.6× 56 0.7× 23 911
Mingyue Wu China 21 224 0.9× 382 1.6× 101 1.0× 173 2.1× 83 1.0× 47 1.1k
Oliviero Marinelli Italy 22 230 0.9× 306 1.3× 114 1.1× 73 0.9× 83 1.0× 41 947
Fenfei Gao China 19 212 0.8× 399 1.6× 63 0.6× 131 1.6× 206 2.6× 62 972
Sung‐Vin Yim South Korea 22 158 0.6× 522 2.1× 117 1.2× 147 1.8× 98 1.2× 61 1.3k
Cui Yang China 19 116 0.4× 423 1.7× 87 0.9× 133 1.6× 79 1.0× 58 930
Mohammad Ebrahim Rezvani Iran 17 130 0.5× 164 0.7× 49 0.5× 58 0.7× 148 1.9× 75 827
Jacqueline Alves Leite Brazil 15 67 0.3× 280 1.1× 89 0.9× 74 0.9× 72 0.9× 27 751
Ryotaro Saiki Japan 18 151 0.6× 415 1.7× 66 0.7× 100 1.2× 54 0.7× 31 761
Yuh‐Fung Chen Taiwan 14 112 0.4× 480 2.0× 96 1.0× 109 1.3× 76 0.9× 28 1.1k

Countries citing papers authored by Eman Soliman

Since Specialization
Citations

This map shows the geographic impact of Eman Soliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman Soliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman Soliman more than expected).

Fields of papers citing papers by Eman Soliman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eman Soliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman Soliman. The network helps show where Eman Soliman may publish in the future.

Co-authorship network of co-authors of Eman Soliman

This figure shows the co-authorship network connecting the top 25 collaborators of Eman Soliman. A scholar is included among the top collaborators of Eman Soliman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eman Soliman. Eman Soliman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soliman, Eman, et al.. (2025). Interrogating mediators of single-cell transcriptional changes in the acute damaged cerebral cortex: Insights into endothelial-astrocyte interactions. Molecular and Cellular Neuroscience. 133. 104003–104003. 3 indexed citations
2.
Soliman, Eman, et al.. (2024). Skull bone marrow-derived immune cells infiltrate the injured cerebral cortex and exhibit anti-inflammatory properties. Brain Behavior and Immunity. 123. 244–253. 6 indexed citations
4.
Soliman, Eman, et al.. (2023). Effect of Implementing Nursing Protocol on clinical Outcomes of Acute Non- variceal Upper Gastrointestinal Bleeding Patients. Tanta Scientific Nursing Journal. 28(1). 290–306. 1 indexed citations
5.
Soliman, Eman, John W. Leonard, Jing Ju, et al.. (2023). Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury. Journal of Neuroinflammation. 20(1). 256–256. 17 indexed citations
6.
Soliman, Eman, John W. Leonard, Kevin J. Pridham, et al.. (2022). Monocyte proinflammatory phenotypic control by ephrin type A receptor 4 mediates neural tissue damage. JCI Insight. 7(15). 13 indexed citations
7.
Ju, Jing, Eman Soliman, Jiang Chen, et al.. (2022). Type I Interferon Response Is Mediated by NLRX1-cGAS-STING Signaling in Brain Injury. Frontiers in Molecular Neuroscience. 15. 852243–852243. 36 indexed citations
8.
Elshazly, Shimaa M., et al.. (2022). Reno-protective effect of mangiferin against methotrexate-induced kidney damage in male rats: PPARγ-mediated antioxidant activity. Saudi Pharmaceutical Journal. 30(9). 1252–1261. 7 indexed citations
9.
Soliman, Eman, et al.. (2022). Efficacy and durability of bovine virus diarrhea (BVD) virus killed vaccine adjuvanted with monolaurin. PLoS ONE. 17(7). e0269031–e0269031. 3 indexed citations
10.
Elshazly, Shimaa M., et al.. (2022). Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway. International Immunopharmacology. 115. 109646–109646. 9 indexed citations
11.
Soliman, Eman, et al.. (2020). Comparative Study Between the Immune Response of DifferentRHDV Vaccines Used in Rabbit Farms in Egypt. 5(12). 84–91. 1 indexed citations
12.
Soliman, Eman, et al.. (2020). Antidepressant activity of anti-hyperglycemic agents in experimental models: A review. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 14(5). 1179–1186. 22 indexed citations
13.
Soliman, Eman, et al.. (2020). Impact of some oral hypoglycemic agents on type 2 diabetes-associated depression and reserpine-induced depression in rats: the role of brain oxidative stress and inflammation. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(8). 1391–1404. 33 indexed citations
14.
Ladin, Daniel A., Eman Soliman, Timothy L. Fitzgerald, et al.. (2017). Synthesis and Evaluation of the Novel Prostamide, 15-Deoxy, Δ12,14-Prostamide J2, as a Selective Antitumor Therapeutic. Molecular Cancer Therapeutics. 16(5). 838–849. 15 indexed citations
15.
Ladin, Daniel A., Eman Soliman, LaToya M. Griffin, & Rukiyah Van Dross. (2016). Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents. Frontiers in Pharmacology. 7. 361–361. 71 indexed citations
18.
Soliman, Eman, et al.. (2015). Apigenin inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice. Prostaglandins Leukotrienes and Essential Fatty Acids. 104. 44–53. 45 indexed citations
19.
Soliman, Eman, et al.. (2013). Effect of Different Inactivators on the Efficacy of Egyptian Foot and Mouth Disease SAT2 Vaccine. 3(8). 392–399. 5 indexed citations
20.
Dross, Rukiyah Van, et al.. (2012). Receptor-dependent and receptor-independent endocannabinoid signaling: A therapeutic target for regulation of cancer growth. Life Sciences. 92(8-9). 463–466. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026